DDX17 and metabolic dysfunction-associated steatohepatitis: Overall, we identified that DDX17 depletion alleviated MCD‐induced NASH, and it might play a role mechanistically in the progression of inflammation and fibrosis through the regulation of lipid metabolism and the activation of M1 macrophages.